Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis

Kazuhiko Bessho1, Shinya Mizuno, Kunio Matsumoto

  • 1Division of Molecular Regenerative Medicine, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Insights

Hepatocyte growth factor (HGF) inhibits the proliferation of activated mesangial cells in glomerulonephritis. HGF counteracts platelet-derived growth factor (PDGF)-induced cell growth by reducing ERK activation.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Medicine

Background:

  • Glomerular mesangial cell activation and proliferation are key in mesangioproliferative glomerulonephritis.
  • The role of hepatocyte growth factor (HGF) in regulating these cells is not fully understood.

Purpose of the Study:

  • To investigate the function of HGF in controlling activated mesangial cell proliferation.
  • To elucidate the molecular mechanisms underlying HGF's effect on mesangial cells.

Main Methods:

  • Induction of anti-Thy 1.1 nephritis in rats to model glomerulonephritis.
  • Assessment of c-Met/HGF receptor expression in normal and diseased glomeruli.
  • In vitro studies using cultured mesangial cells treated with HGF and platelet-derived growth factor (PDGF).
  • Analysis of extracellular signal-regulated kinase (ERK) activation pathways.

Main Results:

  • HGF expression decreased, while c-Met receptor expression increased on activated mesangial cells during nephritis.
  • HGF inhibited PDGF-induced DNA synthesis in cultured mesangial cells.
  • HGF suppressed prolonged ERK activation induced by PDGF.
  • HGF administration in vivo reduced mesangial cell proliferation and ERK phosphorylation in rats with nephritis.

Conclusions:

  • HGF acts as a negative regulator of activated mesangial cell proliferation.
  • HGF counteracts PDGF-induced mesangial cell proliferation, potentially via early inactivation of ERK signaling.

Related Concept Videos